BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19218574)

  • 1. Phosphatidylinositol 3-kinase p85alpha regulatory subunit gene Met326Ile polymorphism in women with polycystic ovary syndrome.
    Kim JJ; Choi YM; Hong MA; Hwang SS; Yoon SH; Chae SJ; Jee BC; Ku SY; Kim JG; Moon SY
    Hum Reprod; 2009 May; 24(5):1184-90. PubMed ID: 19218574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women.
    Márquez JL; Pacheco A; Valdés P; Salazar LA
    Clin Chim Acta; 2008 Dec; 398(1-2):5-9. PubMed ID: 18722363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polymorphism in insulin receptor gene exon 17 in women with polycystic ovary syndrome].
    Jin L; Huang HF; Jin F; Qian YL
    Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):323-6. PubMed ID: 15938783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis of the variant in the regulatory subunit of phosphoinositide 3-kinase (p85alpha) with Type 2 diabetes mellitus and hypertension in the Chinese Han population.
    Chen S; Yan W; Huang J; Ge D; Yao Z; Gu D
    Diabet Med; 2005 Jun; 22(6):737-43. PubMed ID: 15910625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione.
    Panidis D; Kourtis A; Kukuvitis A; Farmakiotis D; Xita N; Georgiou I; Tsatsoulis A
    Hum Reprod; 2004 Aug; 19(8):1728-33. PubMed ID: 15178661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined analyses of paraoxonase-1 and IGF-2 polymorphism in polycystic ovary syndrome].
    Knebel B; Janssen OE; Hahn S; Nitzgen U; Jacob S; Haas J; Mack S; Müller-Wieland D; Kotzka J
    Dtsch Med Wochenschr; 2009 May; 134(20):1040-6. PubMed ID: 19421925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and significance of phosphatidylinositol 3-kinase in adipose tissue of polycystic ovary syndrome patients with insulin resistance].
    Chu YL; Qiu HY; Sun YY; Li M; Li HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):455-8. PubMed ID: 17083810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between common Gly972Arg variant of the insulin receptor substrate-1 and polycystic ovary syndrome in Southern Chilean women.
    Valdés P; Cerda A; Barrenechea C; Kehr M; Soto C; Salazar LA
    Clin Chim Acta; 2008 Apr; 390(1-2):63-6. PubMed ID: 18222120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene and polycystic ovary syndrome.
    Wang K; Wang L; Zhao Y; Shi Y; Wang L; Chen ZJ
    Hum Reprod; 2009 Feb; 24(2):485-90. PubMed ID: 19049992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome.
    Ferk P; Teran N; Gersak K
    Hum Reprod; 2007 Apr; 22(4):1031-6. PubMed ID: 17189294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the relationship between a polymorphism of tumor necrosis factor-alpha gene and the pathogenesis of polycystic ovary syndrome].
    Mao W; Yu L; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2000 Sep; 35(9):536-9. PubMed ID: 11775944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association study between a polymorphism of aldosterone synthetase gene and the pathogenesis of polycystic ovary syndrome].
    Zhao SP; Tang XM; Shao DH; Dai HY; Dai SZ
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):94-7. PubMed ID: 12783697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese population.
    Baba T; Endo T; Sata F; Honnma H; Kitajima Y; Hayashi T; Manase K; Kanaya M; Yamada H; Minakami H; Kishi R; Saito T
    Life Sci; 2007 Aug; 81(10):850-4. PubMed ID: 17719609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of association between the CYP11alpha promoter pentannucleotide (TTTTA)n polymorphism and polycystic ovarian syndrome among Han Chinese women.
    Hao CF; Bao HC; Zhang N; Gu HF; Chen ZJ
    Neuro Endocrinol Lett; 2009 Mar; 30(1):56-60. PubMed ID: 19300392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor beta gene +1730 G/A polymorphism in women with polycystic ovary syndrome.
    Kim JJ; Choi YM; Choung SH; Yoon SH; Lee GH; Moon SY
    Fertil Steril; 2010 Apr; 93(6):1942-7. PubMed ID: 19185861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome.
    Jones MR; Wilson SG; Mullin BH; Mead R; Dudbridge F; Watts GF; Stuckey BG
    Fertil Steril; 2008 Dec; 90(6):2298-303. PubMed ID: 18249389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of the Fas 670 A/G gene polymorphism with cardiovascular risk factors in polycystic ovary syndrome (PCOS) patients.
    Cetinkalp S; Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Ozgen AG; Saygili F; Yilmaz C
    Gynecol Endocrinol; 2010 Mar; 26(3):167-72. PubMed ID: 19718569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype.
    Tok EC; Aktas A; Ertunc D; Erdal EM; Dilek S
    Hum Reprod; 2005 Jun; 20(6):1590-5. PubMed ID: 15705622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homocysteine concentrations and the single nucleotide polymorphisms in the methionine synthase gene (MTR 2756A>G): Associations with the polycystic ovary syndrome An observational study.
    Palep-Singh M; Picton HM; Yates ZR; Barth JH; Balen AH
    Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):180-6. PubMed ID: 18281142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women.
    San Millán JL; Alvarez-Blasco F; Luque-Ramírez M; Botella-Carretero JI; Escobar-Morreale HF
    Hum Reprod; 2006 Dec; 21(12):3157-61. PubMed ID: 16880229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.